Collection: Growth Factors

Our Growth Factors collection features research peptides that have featured prominently in scientific literature relating to the growth hormone axis, GHRH and GHRP signalling, and somatotropic research. All compounds are supplied for laboratory research only and independently tested for purity and peptide identity.

CJC-1295 (without DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been investigated in research relating to pulsatile GH release and somatotropic axis modulation. When combined with Ipamorelin — a selective growth hormone-releasing peptide (GHRP) that acts as a ghrelin receptor agonist — the pairing has been the subject of significant academic interest in studies of synergistic GH-axis stimulation. Our CJC+IPA product supplies both compounds in a single research-grade preparation. GHRP-6 is a hexapeptide ghrelin receptor agonist studied alongside other GHRPs in growth hormone research.

Tesamorelin is a synthetic GHRH analogue that has been studied extensively in clinical research, particularly in relation to visceral adipose tissue and lipodystrophy research models. It carries one of the more substantial bodies of peer-reviewed clinical literature among GHRH analogues. Available in 10mg and 20mg concentrations for research flexibility.

Each batch in this collection is independently HPLC-tested with mass spectrometry confirmation of peptide identity. Typical purity is ≥98% and full Certificate of Analysis documentation is supplied with every order. Reconstitution and storage guidance is included on each product page to support proper handling and peptide stability in laboratory settings.

These research compounds are supplied strictly for laboratory and research purposes. They are not intended for human or veterinary administration, consumption, medical treatment, diagnosis, or therapeutic application.

Same-day UK dispatch on orders placed before 3pm.